Ipratropium Bromide Inhalation
Ipratropium Bromide Inhalation is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Ipratropium Bromide Inhalation. Available dosage form: aerosol.
Drug Details
- Generic Name
- Ipratropium Bromide Inhalation
- Brand Names
- Ipratropium Bromide Inhalation
- Application Number
- ANDA217953
- Sponsor
- Armstrong Pharmaceuticals, Inc.
- NDC Codes
- 1
- Dosage Forms
- AEROSOL
- Routes
- RESPIRATORY (INHALATION)
- Active Ingredients
- IPRATROPIUM BROMIDE
Indications and Usage
1 INDICATIONS AND USAGE Ipratropium bromide HFA inhalation aerosol is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. Ipratropium bromide HFA inhalation aerosol is an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema